6767
台微醫
+0.15 (+0.61%)24.651成交張數–本益比1.69股價淨值比0.00%殖利率2026-09-11資料日期
每股盈餘
柱為單季 EPS,線為近四季合計;近十年
| 季度 | 單季 EPS | 年增 | 近四季 EPS | 歸屬母公司淨利(億) | 淨利率 | ROE(季) | ROE(近四季) |
|---|---|---|---|---|---|---|---|
| 2026Q2 | -0.11 | – | -0.44 | -0.04 | -4.7% | -0.70% | -2.95% |
| 2026Q1 | 0.09 | -30.8% | -0.53 | 0.03 | 4.1% | 0.59% | -3.56% |
| 2025Q4 | -0.51 | – | -0.49 | -0.20 | -30.6% | -3.38% | -3.28% |
| 2025Q3 | 0.09 | – | -0.45 | 0.03 | 3.8% | 0.53% | -3.24% |
| 2025Q2 | -0.20 | – | -0.88 | -0.08 | -9.3% | -1.30% | -5.95% |
| 2025Q1 | 0.13 | – | -0.98 | 0.05 | 6.3% | 0.87% | -6.11% |
| 2024Q4 | -0.47 | – | -1.62 | -0.16 | -16.6% | -3.37% | -10.19% |
| 2024Q3 | -0.34 | – | -1.39 | -0.10 | -10.7% | -2.82% | -11.30% |
| 2024Q2 | -0.30 | -225.0% | -1.40 | -0.09 | -11.8% | -2.55% | -11.12% |
| 2024Q1 | -0.51 | -227.5% | -0.86 | -0.15 | -19.8% | -4.06% | -6.76% |
| 2023Q4 | -0.24 | – | 0.05 | -0.07 | -9.8% | -1.88% | 0.40% |
| 2023Q3 | -0.35 | -537.5% | 0.12 | -0.10 | -13.5% | -2.64% | 0.89% |
| 2023Q2 | 0.24 | – | 0.55 | 0.07 | 10.0% | 1.82% | 4.19% |
| 2023Q1 | 0.40 | – | 0.15 | 0.12 | 17.8% | 3.11% | 1.12% |
| 2022Q4 | -0.17 | – | -0.58 | -0.05 | -9.6% | -1.39% | -4.50% |
| 2022Q3 | 0.08 | – | -0.48 | 0.02 | 4.2% | 0.66% | -3.64% |
| 2022Q2 | -0.16 | – | -0.83 | -0.05 | -9.3% | -1.25% | -6.30% |
| 2022Q1 | -0.33 | – | -1.20 | -0.10 | -22.2% | -2.51% | -8.86% |
| 2021Q4 | -0.07 | – | -1.64 | -0.02 | -4.6% | -0.54% | – |
| 2021Q3 | -0.27 | – | – | -0.08 | -20.5% | -2.00% | – |
| 2021Q2 | -0.53 | – | – | -0.15 | -45.9% | -3.81% | – |
| 2021Q1 | -0.77 | – | – | -0.22 | -81.8% | – | – |